Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × cabazitaxel × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 14 Urinary Bladder Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Cancer, Hereditary, 7 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

venetoclax 27 Azacitidine 25 fludarabine 22 Cyclophosphamide 15 fludarabine phosphate 14 Decitabine 13 Specimen Handling 12 Cytarabine 12 Whole-Body Irradiation 11 Busulfan 11 Biopsy 11 Stem Cell Transplantation 10 Tacrolimus 9 Mycophenolic Acid 9 decitabine and cedazuridine drug combination 8 Granulocyte Colony-Stimulating Factor 8 Methotrexate 7 Melphalan 7 Injections 7 Thiotepa 6 Peripheral Blood Stem Cell Transplantation 5 Idarubicin 5 Filgrastim 5 Daunorubicin 5 Blood Specimen Collection 5 Mesna 4 Cyclosporine 4 Cladribine 4 thymoglobulin 3 olutasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡